These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38081464)

  • 41. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
    Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
    J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
    [No Abstract]   [Full Text] [Related]  

  • 42. Costs associated with febrile neutropenia in the US.
    Michels SL; Barron RL; Reynolds MW; Smoyer Tomic K; Yu J; Lyman GH
    Pharmacoeconomics; 2012 Sep; 30(9):809-23. PubMed ID: 22804805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis.
    Trantham L; Sikirica MV; Candrilli SD; Benson VS; Mohan D; Neil D; Joshi AV
    J Med Econ; 2019 Apr; 22(4):319-327. PubMed ID: 30580639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
    Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
    Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.
    Olson AL; Hartmann N; Patnaik P; Garry EM; Bohn RL; Singer D; Baldwin M; Wallace L
    Adv Ther; 2022 Apr; 39(4):1794-1809. PubMed ID: 35199282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
    Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
    J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
    Exuzides A; To TM; Abbass IM; Ta JT; Patel AM; Surinach A; Fuller RLM; Luo J
    J Med Econ; 2022; 25(1):722-729. PubMed ID: 35608039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of patients with incident non-specific low back pain: implications for research.
    Norton G; McDonough CM; Cabral HJ; Shwartz M; Burgess JF
    Spine J; 2016 May; 16(5):567-76. PubMed ID: 26282103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes.
    Weir MR; Chen YW; He J; Bookhart B; Campbell A; Ashton V
    Diabetes Ther; 2021 Dec; 12(12):3167-3186. PubMed ID: 34699020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases.
    Broder MS; Greene M; Chang E; Hartry A; Touya M; Munday J; Yan T
    Clin Ther; 2018 Oct; 40(10):1670-1682. PubMed ID: 30193748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Healthcare spending and utilization following antireflux surgery: examining costs and reasons for readmission.
    Kleppe KL; Xu Y; Funk LM; Wang X; Havlena JA; Greenberg JA; Lidor AO
    Surg Endosc; 2020 Jan; 34(1):240-248. PubMed ID: 30953200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.
    Insinga RP; Itzler RF; Pellissier JM
    Pharmacoeconomics; 2007; 25(2):155-69. PubMed ID: 17249857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic Low Back Pain with and without Concomitant Osteoarthritis: A Retrospective, Longitudinal Cohort Study of Patients in England.
    Coates G; Clewes P; Lohan C; Stevenson H; Wood R; Tritton T; Knaggs RD; Dickson AJ; Walsh DA
    Int J Clin Pract; 2023; 2023():5105810. PubMed ID: 38020538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial presentation for acute low back pain: is early physical therapy associated with healthcare utilization and spending? A retrospective review of a National Database.
    Marrache M; Prasad N; Margalit A; Nayar SK; Best MJ; Fritz JM; Skolasky RL
    BMC Health Serv Res; 2022 Jul; 22(1):851. PubMed ID: 35778738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Where to start? A two stage residual inclusion approach to estimating influence of the initial provider on health care utilization and costs for low back pain in the US.
    Harwood KJ; Pines JM; Andrilla CHA; Frogner BK
    BMC Health Serv Res; 2022 May; 22(1):694. PubMed ID: 35606781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with persistently high-cost health care utilization for musculoskeletal pain.
    Lentz TA; Harman JS; Marlow NM; Beneciuk JM; Fillingim RB; George SZ
    PLoS One; 2019; 14(11):e0225125. PubMed ID: 31710655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term economic outcomes of ureteral injury in the United States.
    McCarus SD; Shortridge EF; Kimura T; Feng Q; Han W; Jiang B
    Curr Med Res Opin; 2024 Feb; 40(2):325-333. PubMed ID: 37961772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.